A venture capital initiative to launch more life science firms in New York City attracts more backers.
Several companies have joined a growing consortium of backers for a $100m venture capital initiative which looks to launch up to 20 new life science firms in New York City by 2020. Pharmaceutical Eli Lilly joins biotech firm Celgene and GE Ventures, the venture arm of General Electric, in contributing $40m to the initiative. The…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
